CHKA and acute lymphoblastic leukemia: Similarly, the CHKα inhibitor EB-3D, RSM932A or MN58B displays potent anti-proliferative activity against a wide cohort of T-leukemic cell lines as well as primary T-ALL cells collected from pediatric patients at diagnosis via inducing apoptosis [91].